Immune checkpoint reprogramming via sequential nucleic acid delivery strategy optimizes systemic immune responses for gastrointestinal cancer immunotherapy

• Published in: Cancer letters 2024-09, Vol.599, p.217152, Article 217152
• Main Authors: Li, Zhuoyuan, Liu, Xinran, Cai, Nan, Zhou, Zhijun, Huang, Huaping, Wu, Qiang, Xu, Lizhou, Zhu, Wei-Guo, Zhang, Changhua, Wei, Zhewei, Li, Danyang
• Format: Article
• Language: English
• Subjects: Cationic polymer brush nanoplatform; Gastrointestinal cancer immunotherapy; Immune checkpoint reprogramming; Nucleic acid therapy; Sequential delivery
• ISSN: 0304-3835; 1872-7980; 1872-7980
• DOI: 10.1016/j.canlet.2024.217152

Monoclonal antibodies targeting immune checkpoints have been widely applied in gastrointestinal cancer immunotherapy. However, systemic administration of various monoclonal antibodies does not often result in sustained effects in reversing the immunosuppressive tumor microenvironment (TME), which may be due to the spatiotemporal dynamic changes of immune checkpoints. Herein, we reported a novel immune checkpoint reprogramming strategy for gastrointestinal cancer immunotherapy. It was achieved by the sequential delivery of siPD-L1 (siRNA for programmed cell death ligand 1) and pOX40L (plasmid for OX40 ligand), which were complexed with two cationic polymer brush-grafted carbon nanotubes (dense short (DS) and dense long (DL)) designed based on the structural characteristics of nucleic acids and brush architectures. Upon administrating DL/pOX40L for the first three dosages, then followed by DS/siPD-L1 for the next three dosages to the TME, it upregulated the stimulatory checkpoint OX40L on dendritic cells (DCs) and downregulated inhibitory checkpoint PD-L1 on tumor cells and DCs in a sequential reprogramming manner. Compared with other combination treatments, this sequential strategy drastically boosted the DCs maturation, and CD8+ cytotoxic T lymphocytes infiltration in tumor site. Furthermore, it could augment the local antitumor response and improve the T cell infiltration in tumor-draining lymph nodes to reverse the peripheral immunosuppression. Our study demonstrated that sequential nucleic acid delivery strategy via personalized nanoplatforms effectively reversed the immunosuppression status in both tumor microenvironment and peripheral immune landscape, which significantly enhanced the systemic antitumor immune responses and established an optimal immunotherapy strategy against gastrointestinal cancer. •A postive correlation of PD-1/PD-L1 and OX40/OX40L expression was found in colorectal cancer.•Cationic polymer brush-based vectors achieve personalized delivery of siPD-L1 and pOX40L for immune checkpoint reprogramming.•Sequential combination therapy strategy can radically reverse the immunosuppression locally and systemically.•Effective immunotherapy against colorectal cancer was achieved in the mouse model.